
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7142889B743F31C1428003628791C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333986/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity">
<meta name="citation_author" content="Okkeun Jung">
<meta name="citation_author_institution" content="Department of Medical Laboratory Sciences, Hunter College, City University of New York, New York, New York, United States of America">
<meta name="citation_author_institution" content="Ph.D. Program in Biology (Molecular, Cellular, and Developmental Biology Sub-Program), The Graduate Center of the City University of New York, New York, New York, United States of America">
<meta name="citation_author" content="Angelene Soto">
<meta name="citation_author_institution" content="New York Research and Mentoring for Postbaccalaureates at Hunter College of the City University of New York, New York, New York, United States of America">
<meta name="citation_author" content="Andrew L Wolfe">
<meta name="citation_author_institution" content="Ph.D. Program in Biology (Molecular, Cellular, and Developmental Biology Sub-Program), The Graduate Center of the City University of New York, New York, New York, United States of America">
<meta name="citation_author_institution" content="New York Research and Mentoring for Postbaccalaureates at Hunter College of the City University of New York, New York, New York, United States of America">
<meta name="citation_author_institution" content="Department of Biological Sciences, Hunter College of the City University of New York, New York, New York, United States of America">
<meta name="citation_author_institution" content="Ph.D. Program in Biochemistry, The Graduate Center of the City University of New York, New York, New York, United States of America">
<meta name="citation_author_institution" content="Department of Pharmacology, Weill Cornell Medical College, New York, New York, United States of America">
<meta name="citation_author" content="Shahana S Mahajan">
<meta name="citation_author_institution" content="Department of Medical Laboratory Sciences, Hunter College, City University of New York, New York, New York, United States of America">
<meta name="citation_author_institution" content="Ph.D. Program in Biology (Molecular, Cellular, and Developmental Biology Sub-Program), The Graduate Center of the City University of New York, New York, New York, United States of America">
<meta name="citation_author_institution" content="New York Research and Mentoring for Postbaccalaureates at Hunter College of the City University of New York, New York, New York, United States of America">
<meta name="citation_author_institution" content="Ph.D. Program in Biochemistry, The Graduate Center of the City University of New York, New York, New York, United States of America">
<meta name="citation_author_institution" content="Brain Mind Research Institute, Weill Cornell Medical College, New York, New York, United States of America">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0329946">
<meta name="citation_doi" content="10.1371/journal.pone.0329946">
<meta name="citation_pmid" content="40779492">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333986/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333986/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333986/pdf/pone.0329946.pdf">
<meta name="description" content="KRAS mutations, which induce proliferative signaling driving many human cancers, are detectable in a small subset of osteosarcoma patients. The recently developed pan-KRAS inhibitor daraxonrasib, also known as RMC-6236, is capable of targeting a ...">
<meta name="og:title" content="Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="KRAS mutations, which induce proliferative signaling driving many human cancers, are detectable in a small subset of osteosarcoma patients. The recently developed pan-KRAS inhibitor daraxonrasib, also known as RMC-6236, is capable of targeting a ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333986/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12333986">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0329946"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0329946.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12333986%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12333986/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12333986/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333986/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0329946" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 8;20(8):e0329946. doi: <a href="https://doi.org/10.1371/journal.pone.0329946" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329946</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jung%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Okkeun Jung</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Okkeun Jung</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Laboratory Sciences, Hunter College, City University of New York, New York, New York, United States of America</div>
<div class="p">
<sup>2</sup>Ph.D. Program in Biology (Molecular, Cellular, and Developmental Biology Sub-Program), The Graduate Center of the City University of New York, New York, New York, United States of America</div>
<div>Conceptualization, Formal analysis, Investigation, Methodology, Validation, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jung%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Okkeun Jung</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soto%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Angelene Soto</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Angelene Soto</span></h3>
<div class="p">
<sup>3</sup>New York Research and Mentoring for Postbaccalaureates at Hunter College of the City University of New York, New York, New York, United States of America</div>
<div>Methodology</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soto%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Angelene Soto</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wolfe%20AL%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Andrew L Wolfe</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Andrew L Wolfe</span></h3>
<div class="p">
<sup>2</sup>Ph.D. Program in Biology (Molecular, Cellular, and Developmental Biology Sub-Program), The Graduate Center of the City University of New York, New York, New York, United States of America</div>
<div class="p">
<sup>3</sup>New York Research and Mentoring for Postbaccalaureates at Hunter College of the City University of New York, New York, New York, United States of America</div>
<div class="p">
<sup>4</sup>Department of Biological Sciences, Hunter College of the City University of New York, New York, New York, United States of America</div>
<div class="p">
<sup>5</sup>Ph.D. Program in Biochemistry, The Graduate Center of the City University of New York, New York, New York, United States of America</div>
<div class="p">
<sup>6</sup>Department of Pharmacology, Weill Cornell Medical College, New York, New York, United States of America</div>
<div>Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wolfe%20AL%22%5BAuthor%5D" class="usa-link"><span class="name western">Andrew L Wolfe</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>5,</sup><sup>6,</sup><sup>*,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mahajan%20SS%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Shahana S Mahajan</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Shahana S Mahajan</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Laboratory Sciences, Hunter College, City University of New York, New York, New York, United States of America</div>
<div class="p">
<sup>2</sup>Ph.D. Program in Biology (Molecular, Cellular, and Developmental Biology Sub-Program), The Graduate Center of the City University of New York, New York, New York, United States of America</div>
<div class="p">
<sup>3</sup>New York Research and Mentoring for Postbaccalaureates at Hunter College of the City University of New York, New York, New York, United States of America</div>
<div class="p">
<sup>5</sup>Ph.D. Program in Biochemistry, The Graduate Center of the City University of New York, New York, New York, United States of America</div>
<div class="p">
<sup>7</sup>Brain Mind Research Institute, Weill Cornell Medical College, New York, New York, United States of America</div>
<div>Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mahajan%20SS%22%5BAuthor%5D" class="usa-link"><span class="name western">Shahana S Mahajan</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>5,</sup><sup>7,</sup><sup>*,</sup><sup>#</sup>
</div>
<div class="cg p">Editor: <span class="name western">Jin-Ming Zhou</span><sup>8</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Department of Medical Laboratory Sciences, Hunter College, City University of New York, New York, New York, United States of America</div>
<div id="aff002">
<sup>2</sup>Ph.D. Program in Biology (Molecular, Cellular, and Developmental Biology Sub-Program), The Graduate Center of the City University of New York, New York, New York, United States of America</div>
<div id="aff003">
<sup>3</sup>New York Research and Mentoring for Postbaccalaureates at Hunter College of the City University of New York, New York, New York, United States of America</div>
<div id="aff004">
<sup>4</sup>Department of Biological Sciences, Hunter College of the City University of New York, New York, New York, United States of America</div>
<div id="aff005">
<sup>5</sup>Ph.D. Program in Biochemistry, The Graduate Center of the City University of New York, New York, New York, United States of America</div>
<div id="aff006">
<sup>6</sup>Department of Pharmacology, Weill Cornell Medical College, New York, New York, United States of America</div>
<div id="aff007">
<sup>7</sup>Brain Mind Research Institute, Weill Cornell Medical College, New York, New York, United States of America</div>
<div id="edit1">
<sup>8</sup>Zhejiang Normal University, CHINA</div>
<div class="author-notes p">
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>awolfe@genectr.hunter.cuny.edu</span> (ALW); <span>smahajan@hunter.cuny.edu</span> (SSM)</p>
</div>
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></div>
<div class="fn" id="fn001">
<sup>#</sup><p class="display-inline">☯ These authors contributed equally Shahana S. Mahajan and Andrew L. Wolfe.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Okkeun Jung</span></strong>: <span class="role">Conceptualization, Formal analysis, Investigation, Methodology, Validation, Writing – original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Angelene Soto</span></strong>: <span class="role">Methodology</span>
</div>
<div>
<strong class="contrib"><span class="name western">Andrew L Wolfe</span></strong>: <span class="role">Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Shahana S Mahajan</span></strong>: <span class="role">Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Jin-Ming Zhou</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 28; Accepted 2025 Jul 23; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Jung et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12333986  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40779492/" class="usa-link">40779492</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>KRAS mutations, which induce proliferative signaling driving many human cancers, are detectable in a small subset of osteosarcoma patients. The recently developed pan-KRAS inhibitor daraxonrasib, also known as RMC-6236, is capable of targeting a wide array of KRAS mutations and shows promise against pancreatic and lung cancers. However, the efficacy and mechanisms of action of daraxonrasib in osteosarcoma (OS) remain unclear. We evaluated the effects of daraxonrasib on the viability, proliferation, and metastatic potential of wild-type and KRAS mutant OS cells. We assayed the effects of treatment on downstream targets using qPCR, immunoblotting, and activity assays to explore the underlying mechanism by which daraxonrasib selectively suppresses the metastatic potential of KRAS mutant osteosarcoma. Finally, we investigated how the increased prevalence of GTP-bound KRAS enhanced the sensitivity of KRAS wild-type osteosarcoma cells to daraxonrasib using siRNA targeting RASA1. Daraxonrasib selectively attenuated the proliferation and migratory ability of KRAS mutant HOS-143B cells without affecting KRAS wild-type controls. Additionally, daraxonrasib suppressed the expression of the matrix metalloproteases MMP9 and MMP1, which promote cell motility and metastasis. Daraxonrasib selectively inhibited the AKT/ETS1 pathway in HOS-143B cells, whereas no such effect was observed in HOS cells. HOS cells were sensitized to daraxonrasib by knocking down the GTPase-activating protein RASA1. In osteosarcoma, KRAS inhibition decreased MMP1, MMP9, and AKT/ETS1 signaling. Daraxonrasib is a promising agent for treating osteosarcoma with KRAS mutations.</p></section><section id="sec001"><h2 class="pmc_sec_title">Introduction</h2>
<p>Osteosarcoma (OS) is a malignant bone tumor that predominantly occurs during adolescence. Despite the development of anti-cancer drugs targeting osteosarcoma, the survival rate of patients with metastatic osteosarcoma has not improved [<a href="#pone.0329946.ref001" class="usa-link" aria-describedby="pone.0329946.ref001">1</a>].</p>
<p>KRAS is a growth-regulatory GTPase that is frequently mutated in many cancers. Although oncogenic KRAS mutations are rare in human osteosarcoma, they have been previously reported [<a href="#pone.0329946.ref002" class="usa-link" aria-describedby="pone.0329946.ref002">2</a>,<a href="#pone.0329946.ref003" class="usa-link" aria-describedby="pone.0329946.ref003">3</a>]. Oncogenic KRAS G12D and Q61L mutations have been identified in Ewing’s sarcoma samples [<a href="#pone.0329946.ref004" class="usa-link" aria-describedby="pone.0329946.ref004">4</a>–<a href="#pone.0329946.ref006" class="usa-link" aria-describedby="pone.0329946.ref006">6</a>]. KRAS mutations are most commonly found in non-small cell lung cancer (NSCLC), colorectal cancer, and pancreatic cancer [<a href="#pone.0329946.ref007" class="usa-link" aria-describedby="pone.0329946.ref007">7</a>,<a href="#pone.0329946.ref008" class="usa-link" aria-describedby="pone.0329946.ref008">8</a>]. Currently, KRAS G12C is the only mutation that has been successfully targeted using a clinically approved KRAS inhibitors. KRAS G12C inhibitors thus far have only been approved for use as a monotherapy in non-small cell lung cancer and as a combination therapy in colorectal cancer, partially because of the rarity of the G12C allele and partially because of a lack of drug sensitivity in certain tumor types. The extent to which KRAS-mutant osteosarcoma cells are sensitive to KRAS inhibitors remains to be determined.</p>
<p>Several experimental compounds currently in development show promise for targeting other KRAS mutant alleles [<a href="#pone.0329946.ref009" class="usa-link" aria-describedby="pone.0329946.ref009">9</a>–<a href="#pone.0329946.ref011" class="usa-link" aria-describedby="pone.0329946.ref011">11</a>]. Daraxonrasib, also called RMC-6236, is a recently developed pan-RAS inhibitor that targets KRAS in a GTP-bound state irrespective of the driver mutation. Daraxonrasib is a non-covalent inhibitor originally developed from sanglifehrin A, which has a cyclophilin A binding region and a RAS binding region, allowing it to act as a scaffold for a tri-complex that occludes RAS effector binding sites (<a href="#pone.0329946.s001" class="usa-link">S1A Fig</a>) [<a href="#pone.0329946.ref012" class="usa-link" aria-describedby="pone.0329946.ref012">12</a>]. KRAS inhibition leads to decreased binding to its effector RAF1, typically leading to decreased p-ERK and cell proliferation [<a href="#pone.0329946.ref013" class="usa-link" aria-describedby="pone.0329946.ref013">13</a>]. Daraxonrasib halts growth of KRAS-addicted lung cancer and colon cancer cells; however, its efficacy and mechanisms of action in bone cancers have not been evaluated [<a href="#pone.0329946.ref009" class="usa-link" aria-describedby="pone.0329946.ref009">9</a>,<a href="#pone.0329946.ref010" class="usa-link" aria-describedby="pone.0329946.ref010">10</a>].</p>
<p>Metastasis affects nearly 90% of cancer patients and is a significant factor in the high mortality rate [<a href="#pone.0329946.ref014" class="usa-link" aria-describedby="pone.0329946.ref014">14</a>]. In order for cancer to metastasize to other tissues, extracellular matrix (ECM) must initially be degraded, a process facilitated by the secretion of matrix metalloproteases (MMPs) [<a href="#pone.0329946.ref015" class="usa-link" aria-describedby="pone.0329946.ref015">15</a>]. The ECM consists of molecules that surround tissues and organs, providing structural support and serving as a physical barrier [<a href="#pone.0329946.ref016" class="usa-link" aria-describedby="pone.0329946.ref016">16</a>].</p>
<p>In this study, we employed two osteosarcoma cell lines, HOS and HOS-143B, to understand the mechanism of how daraxonrasib affects osteosarcoma with KRAS WT versus the oncogenic mutation KRAS G12S [<a href="#pone.0329946.ref017" class="usa-link" aria-describedby="pone.0329946.ref017">17</a>]. The HOS-143B cell line was established by infecting the HOS cell line with Kirsten mouse sarcoma virus (Ki-ras<sup>+</sup>) [<a href="#pone.0329946.ref018" class="usa-link" aria-describedby="pone.0329946.ref018">18</a>]. Here, we found that treatment with the pan-RAS inhibitor daraxonrasib led to dose-dependent inhibition of growth and migration in the KRAS G12S osteosarcoma cell line HOS-143B, while having virtually no effect on KRAS wild-type osteosarcoma line HOS. Daraxonrasib selectively inhibited MMP1, MMP9, and AKT/ETS1 signaling in HOS-143B cells. These findings support the therapeutic potential of daraxonrasib as an anti-cancer agent for KRAS-mutant osteosarcoma.</p></section><section id="sec002"><h2 class="pmc_sec_title">Results</h2>
<section id="sec003"><h3 class="pmc_sec_title">Daraxonrasib suppresses the proliferation of KRAS mutant osteosarcoma</h3>
<p>We initially measured basal levels of KRAS in both HOS and HOS-143B (143B) cells, confirming that KRAS is overexpressed in HOS-143B cells (<a href="#pone.0329946.s001" class="usa-link">S1B Fig</a>). To address the effect of daraxonrasib on KRAS WT and mutant osteosarcoma, we examined the cytotoxicity of daraxonrasib in HOS and 143B cell lines. The results of both dose-response experiments indicated that daraxonrasib inhibited HOS-143B cells at all tested doses but did not significantly affect the viability of HOS cells (<a href="#pone.0329946.g001" class="usa-link">Fig 1A</a>). This observation suggested that daraxonrasib specifically suppressed the viability of cells with KRAS mutations. To determine whether daraxonrasib affected proliferation over time, we treated HOS-143B and HOS cells with 5 nM daraxonrasib or DMSO for 3 days. As shown in <a href="#pone.0329946.g001" class="usa-link">Fig 1B</a>, daraxonrasib significantly inhibited the proliferation of HOS-143B cells. In contrast, HOS cell growth was not suppressed by daraxonrasib. The basal proliferation rate of HOS-143B cells was significantly higher than that of HOS cells (<a href="#pone.0329946.g001" class="usa-link">Fig 1B</a>). Next, we examined the long-term anti-proliferative effects of daraxonrasib on both cell lines by performing a colony formation assay over eight days. Treatment with daraxonrasib significantly reduced colony number of HOS-143B cells, while not affecting HOS cells (<a href="#pone.0329946.g001" class="usa-link">Figs 1C</a> and <a href="#pone.0329946.g001" class="usa-link">D</a>). These results imply that daraxonrasib selectively inhibits the growth of mutant KRAS osteosarcoma.</p>
<figure class="fig xbox font-sm" id="pone.0329946.g001"><h4 class="obj_head">Fig 1. Pan-KRAS inhibition selectively halts proliferation of KRAS G12S HOS-143B cells.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333986_pone.0329946.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aae4/12333986/a197d0d2250a/pone.0329946.g001.jpg" loading="lazy" height="403" width="682" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329946.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Cytotoxicity of daraxonrasib in HOS-143B and HOS cells. (B) Proliferation assay across three days of treatment with DMSO or 5 nM daraxonrasib in HOS and 143B cell lines. (C-D) Colony forming assay and quantification of colony numbers of (C) HOS-143B and (D) HOS. All experiments were conducted independently in triplicate. Data are presented as the means ± SD. Student’s t-test was conducted to assess the significance of two-group comparisons. For comparisons involving more than three groups, one-way ANOVA was performed, followed by Dunnett’s test for post-hoc analysis to determine statistical significance. *<em>p</em> &lt; .05, **<em>p</em> &lt; .01, ***<em>p</em> &lt; .001, ****<em>p</em> &lt; .0001.</p></figcaption></figure></section><section id="sec004"><h3 class="pmc_sec_title">Daraxonrasib selectively inhibits metastatic potential of HOS-143B cells</h3>
<p>To investigate whether daraxonrasib has an anti-cancer effect, we performed wound healing and invasion assays (<a href="#pone.0329946.g002" class="usa-link">Fig 2</a>). Notably, daraxonrasib selectively inhibited the migratory and invasive abilities of HOS-143B cells (<a href="#pone.0329946.g002" class="usa-link">Figs 2A</a> and <a href="#pone.0329946.g002" class="usa-link">2C</a>). The invasive abilities of HOS cells remained unchanged following daraxonrasib treatment (<a href="#pone.0329946.g002" class="usa-link">Figs 2B</a> and <a href="#pone.0329946.g002" class="usa-link">2D</a>). These results suggested that daraxonrasib suppresses pathways relevant to cancer metastasis in a KRAS mutation-selective manner.</p>
<figure class="fig xbox font-sm" id="pone.0329946.g002"><h4 class="obj_head">Fig 2. Daraxonrasib selectively impedes the metastatic ability of HOS-143B cells.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333986_pone.0329946.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aae4/12333986/1044d3983864/pone.0329946.g002.jpg" loading="lazy" height="609" width="750" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329946.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Wound healing assays were performed to examine migratory ability of (A) HOS-143B and (B) HOS cells. Both cell lines were seeded on 96-well plates, plates were scratched using a 200 µl pipette tip, and cells were incubated overnight with either DMSO or daraxonrasib (5 nM and 10 nM). Media containing 0.1% serum was used as a negative control (-). The negative control shows the initial wound distance. (C-D) A Boyden chamber invasion assay was conducted to access the invasive abilities of (C) HOS-143B and (D) HOS cells. Scale bars represent 200 µm and 100 µm for the wound healing assay and Boyden chamber invasion assay, respectively. All experiments were conducted independently in triplicate, and the data are presented as the means ± SD. One-way ANOVA was performed, followed by Dunnett’s test for post-hoc analysis to determine statistical significance. *<em>p</em> &lt; .05, **<em>p</em> &lt; .01, ***<em>p</em> &lt; .001.</p></figcaption></figure></section><section id="sec005"><h3 class="pmc_sec_title">Daraxonrasib inhibits MMP-9 activity in HOS-143B</h3>
<p>Upregulation of MMP9 by activation of the PI3K/AKT pathway has been demonstrated to promote osteosarcoma migration [<a href="#pone.0329946.ref019" class="usa-link" aria-describedby="pone.0329946.ref019">19</a>]. In addition, MMP2 and MMP9 have been proposed as markers for metastasis and angiogenesis [<a href="#pone.0329946.ref020" class="usa-link" aria-describedby="pone.0329946.ref020">20</a>]. To determine whether daraxonrasib inhibits MMP2 and MMP9 activities, we conducted gelatin zymography in the presence or absence of daraxonrasib (5 and 10 nM). MMP2 activity was upregulated by daraxonrasib in HOS-143B cells (<a href="#pone.0329946.g003" class="usa-link">Fig 3A</a>), whereas MMP9 activity was significantly inhibited by daraxonrasib (<a href="#pone.0329946.g003" class="usa-link">Fig 3B</a>). Neither MMP2 nor MMP9 activities were altered by daraxonrasib in HOS cells (<a href="#pone.0329946.g003" class="usa-link">Figs 3C</a> and <a href="#pone.0329946.g003" class="usa-link">D</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329946.g003"><h4 class="obj_head">Fig 3. Daraxonrasib inhibits MMP9 expression while upregulating MMP2 expression in HOS-143B cells.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aae4/12333986/0d9117442dd6/pone.0329946.g003.jpg" loading="lazy" height="1495" width="800" alt="Fig 3"></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329946.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Gelatin zymography demonstrated that enzymatic activities of (A) MMP2 and (B) MMP9 in HOS-143B were affected by daraxonrasib. The activities of MMP2 (C) and MMP9 (D) in HOS cells remained unchanged following daraxonrasib treatment. (E) qPCR for MMP2 or MMP9 demonstrated that daraxonrasib upregulated MMP2 mRNA expression while suppressing MMP9 mRNA expression in HOS-143B. (F) Daraxonrasib had no effect on MMP2 and MMP9 mRNA expression in HOS. All experiments were conducted independently in triplicate. The data are presented as the means ± SD. One-way ANOVA was performed, followed by Dunnett’s test for post-hoc analysis to determine statistical significance. *<em>p</em> &lt; .05, **<em>p</em> &lt; .01, ***<em>p</em> &lt; .001.</p></figcaption></figure><p>Next, we investigated whether daraxonrasib affected the mRNA levels of MMP2 and MMP9. Similar to its effect on MMP2 and MMP9 activities, daraxonrasib significantly increased MMP2 mRNA expression and significantly decreased MMP9 mRNA expression in HOS-143B cells (<a href="#pone.0329946.g003" class="usa-link">Fig 3E</a>), while having no effect on MMP2 or MMP9 mRNA expression in HOS cells (<a href="#pone.0329946.g003" class="usa-link">Fig 3F</a>).</p></section><section id="sec006"><h3 class="pmc_sec_title">Daraxonrasib dramatically inhibits MMP1 activity in HOS-143B</h3>
<p>MMP1 activity has been reported to stimulate angiogenesis and endothelial cell proliferation through upregulation of VEGFR2 [<a href="#pone.0329946.ref021" class="usa-link" aria-describedby="pone.0329946.ref021">21</a>]. HOS-143B has also been shown to exhibit high expression of MMP1 and MMP9 [<a href="#pone.0329946.ref022" class="usa-link" aria-describedby="pone.0329946.ref022">22</a>]. Therefore, we evaluated MMP1 mRNA expression in seven osteosarcoma cell lines, including HOS and HOS-143B. MMP1 showed the highest expression in HOS-143B cells among all osteosarcoma cell lines (<a href="#pone.0329946.g004" class="usa-link">Fig 4A</a>). To determine whether daraxonrasib affected MMP1 expression, we examined MMP1 activity using collagen zymography. The results indicated that MMP1 was significantly downregulated by daraxonrasib in HOS-143B cells, but not in HOS cells (<a href="#pone.0329946.g004" class="usa-link">Figs 4B</a> and <a href="#pone.0329946.g004" class="usa-link">C</a>). In addition, we evaluated mRNA of MMP1 in HOS and HOS-143B cells and confirmed that MMP1 mRNA was selectively suppressed only in HOS-143B cells (<a href="#pone.0329946.g004" class="usa-link">Figs 4D</a> and <a href="#pone.0329946.g004" class="usa-link">E</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329946.g004"><h4 class="obj_head">Fig 4. Daraxonrasib effectively suppresses MMP1 expression in HOS-143B cells.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333986_pone.0329946.g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aae4/12333986/48b8302aa06f/pone.0329946.g004.jpg" loading="lazy" height="626" width="786" alt="Fig 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329946.g004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) comparison of MMP1 mRNA expression in osteosarcoma cell lines. (B-E) Gelatin zymography demonstrated that daraxonrasib inhibited MMP1 activity in (B) HOS-143B, while the MMP1 activity remained unchanged in (C) HOS cells. (D) qPCR demonstrated that daraxonrasib downregulated MMP1 mRNA expression in HOS-143B. (E) Daraxonrasib does not alter the MMP1 mRNA expression in HOS cells. All experiments were conducted independently in triplicate. The data are presented as the means ± SD. One-way ANOVA was performed, followed by Dunnett’s test for post-hoc analysis to determine statistical significance. An asterisk (*) in (A) indicates a comparison of 143B expression to each osteosarcoma cell line. *<em>p</em> &lt; .05, **<em>p</em> &lt; .01, ***<em>p</em> &lt; .001.</p></figcaption></figure></section><section id="sec007"><h3 class="pmc_sec_title">Daraxonrasib attenuates AKT/ETS1 signaling in HOS-143B</h3>
<p>Daraxonrasib recruits CYPA to KRAS to block KRAS interaction with downstream effectors, such as RAF and PI3K [<a href="#pone.0329946.ref023" class="usa-link" aria-describedby="pone.0329946.ref023">23</a>]. Thus, we hypothesized that daraxonrasib selectively suppresses the invasive ability of HOS-143B cells by suppressing the RAF/MEK/ERK and PI3K/AKT signaling axes [<a href="#pone.0329946.ref009" class="usa-link" aria-describedby="pone.0329946.ref009">9</a>,<a href="#pone.0329946.ref024" class="usa-link" aria-describedby="pone.0329946.ref024">24</a>]. Daraxonrasib reduced the active phosphorylated form of ERK1/2 in HOS-143B cells (<a href="#pone.0329946.g005" class="usa-link">Fig 5A</a>). Strikingly, at higher doses daraxonrasib inhibited the active form of ERK1/2 in HOS cells as well (<a href="#pone.0329946.g005" class="usa-link">Fig 5B</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329946.g005"><h4 class="obj_head">Fig 5. Effects of daraxonrasib on p-ERK, p-AKT and ETS1 in HOS-143B and HOS cells.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333986_pone.0329946.g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aae4/12333986/193d8e9dba99/pone.0329946.g005.jpg" loading="lazy" height="828" width="673" alt="Fig 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329946.g005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A-B) Cells were treated with daraxonrasib (5 nM and 10 nM) for 24 hours. Daraxonrasib treatment downregulated ERK1/2 phosphorylation in both (A) HOS-143B and (B) HOS cells. (C) Daraxonrasib treatment reduced AKT phosphorylation in 143B cells. (D) AKT phosphorylation remained unaffected in HOS cells. (E) ETS1 is downregulated by daraxonrasib treatment in HOS-143B. (F) Daraxonrasib does not attenuate ETS1 levels in HOS cells. (G-H) qPCR for 143B (G) or HOS (H) cells treated with the indicated doses of daraxonrasib for 24 hours. All experiments were conducted independently in triplicate. The data are presented as the means ± SD. One-way ANOVA was performed, followed by Dunnett’s test for post-hoc analysis to determine statistical significance. *<em>p</em> &lt; .05, **<em>p</em> &lt; .01, ***<em>p</em> &lt; .001.</p></figcaption></figure><p>ETS1 is a metastasis-regulating transcription factor regulated by AKT in NSCLC [<a href="#pone.0329946.ref025" class="usa-link" aria-describedby="pone.0329946.ref025">25</a>]. Daraxonrasib treatment suppressed phosphorylation of AKT and the expression of ETS1 in HOS-143B cells, while no change was observed in HOS cells (<a href="#pone.0329946.g005" class="usa-link">Fig 5 C-F</a>).</p></section><section id="sec008"><h3 class="pmc_sec_title">Daraxonrasib selectively inhibits the transcriptional activity of ETS1 in HOS-143B</h3>
<p>Next, we hypothesized that daraxonrasib-mediated downregulation of ETS1 would attenuate the transcriptional activity of ETS1-regulated target genes. To evaluate transcriptional activity of ETS1, we performed qPCR and examined expression of three previously reported ETS1 targets involved in promoting cell proliferation: CCN1, CCN2, and CCND1 [<a href="#pone.0329946.ref025" class="usa-link" aria-describedby="pone.0329946.ref025">25</a>–<a href="#pone.0329946.ref027" class="usa-link" aria-describedby="pone.0329946.ref027">27</a>]. The results demonstrated that these genes were downregulated by treatment with daraxonrasib in HOS-143B (<a href="#pone.0329946.g005" class="usa-link">Fig 5G</a>). Daraxonrasib did not change mRNA expression of these genes in HOS cells (<a href="#pone.0329946.g005" class="usa-link">Fig 5H</a>). These results suggest that daraxonrasib inhibits AKT/ETS1 signaling in KRAS mutant cells, resulting in suppression of CCN1, CCN2, and CCND1 expression.</p></section><section id="sec009"><h3 class="pmc_sec_title">The inhibitory effect of daraxonrasib depends on the duration of active KRAS persistence</h3>
<p>KRAS mutations enable cancer cells to proliferate by maintaining a higher proportion of KRAS in the active GTP-bound state [<a href="#pone.0329946.ref028" class="usa-link" aria-describedby="pone.0329946.ref028">28</a>]. Thus, we hypothesized that an increase in active KRAS may sensitize osteosarcoma cells with WT KRAS to inhibition by daraxonrasib. To test this hypothesis, we used siRNA to silence RASA1 expression in HOS cells. RASA1 encodes the protein p120-RasGAP, a GTPase-activating protein (GAP) that promotes the conversion of active KRAS-GTP into its inactive form KRAS-GDP via hydrolysis [<a href="#pone.0329946.ref029" class="usa-link" aria-describedby="pone.0329946.ref029">29</a>]. RASA1 expression was efficiently suppressed by si-RASA1 at both the mRNA (<a href="#pone.0329946.g006" class="usa-link">Fig. 6A</a>) and protein levels (<a href="#pone.0329946.g006" class="usa-link">Fig. 6B</a>). To investigate whether RASA1 knockdown leads to increased GTP-bound KRAS levels in HOS cells, we performed GTP-KRAS pull-down assay. The results showed that the suppression of RASA1 significantly increased GTP-KRAS levels compared to the si-Scramble in HOS cells (<a href="#pone.0329946.g006" class="usa-link">Fig 6C</a>). Under these conditions, we evaluated the cytotoxicity of daraxonrasib using si-Scramble and si-RASA1. Intriguingly, daraxonrasib significantly inhibited the viability of HOS cells transfected with an siRNA against RASA1 in a dose-dependent manner, whereas no effect was observed in HOS cells transfected with si-Scramble (<a href="#pone.0329946.g006" class="usa-link">Fig 6D</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329946.g006"><h4 class="obj_head">Fig 6. A higher proportion of active KRAS exhibit greater sensitivity to daraxonrasib.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333986_pone.0329946.g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aae4/12333986/6ebf9dd7ca96/pone.0329946.g006.jpg" loading="lazy" height="989" width="762" alt="Fig 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329946.g006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) qPCR analysis of <em>RASA1</em> mRNA and (B) protein expression of RASA1 following treatment with a siRNA targeting RASA1. (C) The effect of <em>RASA1</em> silencing on GTP-bound KRAS levels was assessed in HOS cell line. GTP-KRAS expression was evaluated using HOS-143B cells as a positive indicator. (D) Dose response relative viability for cells treated with siRASA1 or a Scrambled siRNA negative control. All experiments were conducted independently in triplicate, and the data are presented as the means ± SDs. One-way ANOVA was performed, followed by Dunnett’s test for post-hoc analysis to determine statistical significance. Student’s t-test was used to determine the statistical significance between the si-scramble and si-RASA groups at the same dosage. Asterisk (*) indicates comparison to DMSO, Hash (<sup>#</sup>) indicates comparison to si-scramble at same dosage. *<em>p</em> &lt; .05, **<em>p</em> &lt; .01, ***<em>p</em> &lt; .001. <sup>#</sup><em>p</em> &lt; .05, <sup>##</sup><em>p</em> &lt; .01, <sup>###</sup><em>p</em> &lt; .001.</p></figcaption></figure></section></section><section id="sec010"><h2 class="pmc_sec_title">Discussion</h2>
<p>Single-agent basket clinical trials of the KRAS G12C inhibitors adagrasib and sotorasib led to approval in NSCLC, but not in other diseases [<a href="#pone.0329946.ref011" class="usa-link" aria-describedby="pone.0329946.ref011">11</a>,<a href="#pone.0329946.ref030" class="usa-link" aria-describedby="pone.0329946.ref030">30</a>–<a href="#pone.0329946.ref033" class="usa-link" aria-describedby="pone.0329946.ref033">33</a>]. Daraxonrasib is currently in two Phase 3 clinical trials, one for NSCLC and another for pancreatic ductal adenocarcinoma (PDAC). Bone cancers have not been traditionally well represented in KRAS inhibitor clinical trials because of the low frequency of KRAS mutations and the infrequency of G12C. The recent expansion of the range of druggable KRAS alleles has opened new clinical opportunities to treat rare KRAS-mutant bone cancers.</p>
<p>Here, we discovered that daraxonrasib selectively inhibits the invasive and proliferative abilities of osteosarcoma cells with KRAS mutations. In wound healing assays, we observed some inhibition of the metastatic ability of HOS cells by daraxonrasib at a concentration of 10 nM, although the effect was not significant (<a href="#pone.0329946.g002" class="usa-link">Fig 2B</a>). It is conceivable that osteosarcoma with KRAS WT can still be affected by daraxonrasib, and that increasing concentrations of daraxonrasib may inhibit the invasive ability of osteosarcomas with wild-type KRAS. In addition, we confirmed that MMP1 and MMP9 were regulated by daraxonrasib only in 143B-HOS cells. It has been reported that MMP1 and MMP9 are regulated by ETS1 activation [<a href="#pone.0329946.ref034" class="usa-link" aria-describedby="pone.0329946.ref034">34</a>–<a href="#pone.0329946.ref036" class="usa-link" aria-describedby="pone.0329946.ref036">36</a>]. Therefore, the inhibition of MMP1 and MMP9 may result from the suppression of AKT/ETS1 signaling.</p>
<p>Several natural compounds have demonstrated anti-cancer effects in NSCLC and prostate cancer through concurrent inhibition of MMP2 and MMP9 expressions [<a href="#pone.0329946.ref037" class="usa-link" aria-describedby="pone.0329946.ref037">37</a>,<a href="#pone.0329946.ref038" class="usa-link" aria-describedby="pone.0329946.ref038">38</a>]. Notably, daraxonrasib treatment resulted in suppressed MMP9 expression while concurrently increasing MMP2 expression. This dichotomous effect of daraxonrasib on MMP2 and MMP9 suggests the involvement of a distinct regulatory mechanism influenced by KRAS inhibition. Mutant KRAS halts calcium influx by remodeling STIM expression in colorectal cancer cells [<a href="#pone.0329946.ref039" class="usa-link" aria-describedby="pone.0329946.ref039">39</a>]. Thus, KRAS inhibition by daraxonrasib may lead to increased intracellular calcium levels, potentially activating calcium-dependent signaling pathways such as CREB [<a href="#pone.0329946.ref040" class="usa-link" aria-describedby="pone.0329946.ref040">40</a>–<a href="#pone.0329946.ref042" class="usa-link" aria-describedby="pone.0329946.ref042">42</a>]. Activation of cyclic AMP response element binding protein (CREB) has been reported to induce MMP2 expression in cholangiocarcinoma [<a href="#pone.0329946.ref040" class="usa-link" aria-describedby="pone.0329946.ref040">40</a>]. In contrast, MMP9 expression, particularly in neutrophils, has been shown to be IL-8–mediated and independent of intracellular calcium levels. Therefore, the selective upregulation of MMP2 observed following daraxonrasib treatment may be attributed to calcium-mediated mechanisms triggered by KRAS inhibition. Further studies are needed to elucidate the mechanism by which daraxonrasib upregulates MMP2 while concurrently suppressing MMP9.</p>
<p>Since daraxonrasib selectively inhibited the cytotoxicity and metastatic ability of HOS-143B, it was expected to selectively inhibit the phosphorylation of ERK1/2 in osteosarcoma cells with mutant KRAS. Remarkably, we also observed suppression of p-ERK1/2 in HOS cells at higher doses (<a href="#pone.0329946.g005" class="usa-link">Fig 5B</a>). Taken together, these results suggest that daraxonrasib may inhibit proliferation and metastasis via a pathway other than ERK1/2 suppression. Evaluation of the basal level of KRAS in both HOS and HOS-143B cells indicated that KRAS was significantly higher in HOS-143B cells (<a href="#pone.0329946.s001" class="usa-link">S1B Fig</a>). Therefore, the metabolic system and proliferation of HOS-143B cells might be optimized by KRAS overexpression compared to HOS cells, leading to increased vulnerability and proliferation in response to daraxonrasib. We further demonstrated that daraxonrasib inhibition of osteosarcoma depended on the ratio of the active form of KRAS, as demonstrated by the increased daraxonrasib sensitivity of HOS cells that was induced by knockdown of RASA1. (<a href="#pone.0329946.g006" class="usa-link">Fig 6D</a>).</p>
<p>Based on the present findings, we propose a mechanism by which daraxonrasib suppresses the proliferation and metastatic ability of KRAS mutant osteosarcoma cells by inhibiting overactive AKT/ETS1 signaling (<a href="#pone.0329946.g007" class="usa-link">Fig 7</a>). The targeted anti-cancer effect of daraxonrasib highlights its potential as a therapeutic agent for osteosarcoma patients with KRAS mutations. WT KRAS tumors with GAP deficiencies that induce an elevated proportion of active GTP-bound KRAS may be sensitive to daraxonrasib, a possibility that could further expand the use of daraxonrasib for new patient populations with osteosarcoma and beyond.</p>
<figure class="fig xbox font-sm" id="pone.0329946.g007"><h3 class="obj_head">Fig 7.  The proposed mechanism by which daraxonrasib exerts its effect involves inhibition of the active form of KRAS, which in turn suppresses AKT/ETS signaling, resulting in the downregulation of MMP1, MMP9, CCN1, CCN2, and CCND1 expression.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333986_pone.0329946.g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aae4/12333986/2822e28a70f9/pone.0329946.g007.jpg" loading="lazy" height="373" width="762" alt="Fig 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329946.g007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Normal status of (A) HOS cells and (B) HOS-143B cells. Effects of daraxonrasib treatment on (C) HOS cells and (D) HOS-143B cells.</p></figcaption></figure></section><section id="sec011"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="sec012"><h3 class="pmc_sec_title">Compounds</h3>
<p>Daraxonrasib was obtained from MedChem Express. The structure of daraxonrasib was drawn using ChemDraw.</p></section><section id="sec013"><h3 class="pmc_sec_title">Cell culture</h3>
<p>hFOB 1.19 (CRL-3602), MG63 (CRL-1427), HOS (CRL-1543), HOS-MNNG (CRL-1547), HOS-143B (CRL-8303), Saos2 (HTB-85), and U2OS (HTB-96) were purchased from ATCC. hFOB 1.19 cells were incubated in DMEM without phenol red containing 10% FBS, and 1% penicillin and streptomycin. U2OS and Saos2 cells were incubated in McCoy’s 5A without phenol red containing 10% FBS and 1% penicillin and streptomycin. MNNG, MG63 and HOS cells were incubated in EMEM containing 10% FBS, and 1% penicillin and streptomycin. HOS-143B cells were incubated in DMEM containing 10% FBS, BrdU, and 1% penicillin and streptomycin. Cells were maintained in a humidified atmosphere of 37°C, and 5% CO<sub>2</sub>.</p></section><section id="sec014"><h3 class="pmc_sec_title">Proliferation assay</h3>
<p>Cells were seeded in 96-well plates at a density of 1.0 × 10<sup>4</sup> cells per well for 24-hour treatment. The cells were treated with DMSO or various doses of daraxonrasib (3, 5, 6, 10, 15, 30, 60, or 100 nM). After treatment, the cells were incubated with MTT solution (5 mg/ml) for 1 h. The media was then replaced with DMSO. Colorimetric changes were measured at 570 nm using a microplate reader.</p>
<p>To investigate the long-term effect of daraxonrasib on HOS and HOS-143B cells, 3 × 10<sup>3</sup> of HOS or HOS-143B cells were seeded into four separate 96-well plates. On the following day, cells were treated with either DMSO or 5 nM daraxonrasib. One plate was subjected to MTT assay immediately after treatment (Day 0). Subsequently, MTT assay was performed on one plate at the same time each day. All MTT values were normalized to those of Day 0.</p></section><section id="sec015"><h3 class="pmc_sec_title">Colony formation assay</h3>
<p>Two hundred HOS and HOS-143B cells were seeded in 6-well plates. The following day, the cells were treated with DMSO or 5 nM daraxonrasib for eight days. On the fourth day, the media was replaced with fresh media with DMSO or daraxonrasib. After eight days, cells were fixed with methanol at – 20°C for 1 h. Fixed cells were stained with 0.1% crystal violet solution containing 20% methanol. Stained cells were washed twice with PBS. The number of colonies was quantified using ImageJ software.</p></section><section id="sec016"><h3 class="pmc_sec_title">Wound healing migration assay</h3>
<p>HOS and HOS-143B cells were seeded in a 96-well plate at densities of 1.2 × 10<sup>4</sup> cells per well and 1.5 × 10<sup>4</sup> cells per well, respectively. The following day, the center of each well was scraped using a 200 µl micropipette tip. The wells were washed with PBS and treated with culture media containing either DMSO, or daraxonrasib at 5 nM or 10 nM. Media containing 0.1% FBS was used as a negative control. The following day, cells were fixed with methanol and incubated at −20°C for 1 h. After fixation, the cells were stained with 0.1% crystal violet and the wound area was imaged under a microscope. For each image, the gap was measured at three different points and averaged. These average values were used to evaluate the effect of daraxonrasib on the migratory abilities of HOS and HOS-143B cells.</p></section><section id="sec017"><h3 class="pmc_sec_title">Boyden chamber invasion assay</h3>
<p>The polycarbonate membrane with 8 µm pore size was coated with gelatin coating solution (0.1% acetic acid and 0.02% gelatin) for 1 h. Media containing 0.1% FBS was used as a negative control. The media containing 1% FBS with either DMSO or daraxonrasib (5 or 10 nM) was added to the lower chamber. Then, the gelatin-coated membrane and upper chamber were placed on top. Cells were collected and resuspended in 0.1% FBS media. The cell suspension was then added to the upper chamber and incubated in a cell culture incubator. After incubation, the membrane was fixed with methanol at −20°C for 2 h. Following fixation, the membrane was stained with 0.1% crystal violet solution. The membrane facing the upper chamber was gently wiped with Kimwipes soaked in 30% glycerol to remove non-invading cells. The invading cells were imaged using a microscope (Zeiss, Scipe.A1) and quantified.</p></section><section id="sec018"><h3 class="pmc_sec_title">Gelatin &amp; collagen zymography</h3>
<p>Cells were treated with either DMSO or daraxonrasib in the media containing 0.1% FBS for 48 h. The media was collected and quantified using the Bradford assay. Electrophoresis was performed using a gel containing gelatin (Sigma, G2500) or collagen I (Gibco, A1048301). After electrophoresis, the gel was washed with 2.5% Triton X-100 three times and developed with developing solution [50mM Tris-HCl (pH 7.6) and 5mM CaCl<sub>2</sub>] for two days. The developed gel was stained with a staining solution (Coomassie Blue) and a destaining solution. Images were quantified using ImageJ software.</p></section><section id="sec019"><h3 class="pmc_sec_title">RNA extraction and qPCR</h3>
<p>RNA was extracted using an RNeasy RNA Purification Kit (Qiagen, Hilden, Germany). The extracted RNA was quantified using a NanoDrop. The isolated mRNA was converted to cDNA using a LunaScript cDNA synthesis kit from NEB. Real-time PCR was performed using the Power SYBR Green PCR master mix (Thermo Fisher Scientific). Primer sequences used for qPCR are described in the primer table below. Ct values were obtained by performing qPCR using QuantStudio 7 Flex (Applied Biology Systems). The 2<sup>ΔΔCt</sup> method was used to examine the relative mRNA expression.</p></section><section id="sec020"><h3 class="pmc_sec_title">Primer table</h3>
<section class="tw xbox font-sm" id="pone.0329946.t001"><div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Target gene</th>
<th align="left" rowspan="1" colspan="1">Forward primer</th>
<th align="left" rowspan="1" colspan="1">Reverse primer</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">GAPDH</td>
<td align="left" rowspan="1" colspan="1">TGCACCACCAACTGCTTAGC</td>
<td align="left" rowspan="1" colspan="1">GGCATGGACTGTGGTCATGAG</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MMP1</td>
<td align="left" rowspan="1" colspan="1">ATGCGAACAAATCCCTTCTACC</td>
<td align="left" rowspan="1" colspan="1">TTTCCTCAGAAAGAGCAGCATCG</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MMP2</td>
<td align="left" rowspan="1" colspan="1">TTGACGGTAAGGACGGACTC</td>
<td align="left" rowspan="1" colspan="1">ACTTGCAGTACTCCCCATCG</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MMP9</td>
<td align="left" rowspan="1" colspan="1">GAGACCGGT GAG CTG GAT</td>
<td align="left" rowspan="1" colspan="1">TACACGCGAGTGAAGGTG AG</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CCN2</td>
<td align="left" rowspan="1" colspan="1">CTTGCGAAGCTGACCTGGAAGA</td>
<td align="left" rowspan="1" colspan="1">CCGTCGGTACATACTCCACAGA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CCN1</td>
<td align="left" rowspan="1" colspan="1">GGAAAAGGCAGCTCACTGAAGC</td>
<td align="left" rowspan="1" colspan="1">GGAGATACCAGTTCCACAGGTC</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CCND1</td>
<td align="left" rowspan="1" colspan="1">CCTGTCCTACTACCGCCTCA</td>
<td align="left" rowspan="1" colspan="1">CAGTCCGGGTCACACTTGA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RASA1</td>
<td align="left" rowspan="1" colspan="1">GGCCGGGAAGAAGATCCAC</td>
<td align="left" rowspan="1" colspan="1">GCAGACTTGACCAACTGTCATT</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0329946.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec021"><h3 class="pmc_sec_title">Immunoblots</h3>
<p>HOS and HOS-143 cells were seeded in 60-mm dishes (4.0 × 10<sup>5</sup>). The following day, cells were incubated with DMSO or daraxonrasib (5 and 10 nM) for 24 h. After treatment, cells were harvested and lysed using RIPA lysis buffer containing protease and phosphatase inhibitors. Cell lysates were normalized using the BCA protein assay kit (Thermo Fisher Scientific). After quantification of samples, the samples were mixed with 6x loading sample buffer containing 5% β-mercaptoethanol and boiled at 95°C for 10 min. SDS-PAGE was then performed and the proteins were transferred onto a PVDF membrane (Thermo Fisher, USA). After transfer, the membrane was incubated with blocking buffer (5% skim milk in TBST) for 1 h. After blocking, the membranes were incubated with target antibodies overnight at 4°C in shaking incubator. The following day, the membrane was washed by TBST three times and incubated with secondary antibody in TBST containing 1% skim milk. After secondary antibody incubation, an ECL solution (Thermo Fisher) was applied to the membrane and the target bands were detected using LI-COR. The following antibodies were used: KRAS (Proteintech, 12063–1-AP), β-actin (Santa Cruz Technology, SC-47778), p-ERK1/2 (Cell Signaling Technology, 9101S), ERK1/2 (Cell Signaling Technology, 9102), GAPDH (Cell Signaling Technology, 5174S), p-AKT S473 (Cell Signaling Technology, 4060S), AKT (Cell Signaling Technology, 4691S), ETS1 (Cell Signaling Biotechnology, 14069S), α-tubulin (Cell Signaling Technology, 3873S), and RASA1 (Proteintech, 12935–1-AP).</p></section><section id="sec022"><h3 class="pmc_sec_title">Transfection</h3>
<p>HOS cells were seeded at 8,000 cells per well in a 96-well plate. The following day, HOS cells were transfected with scrambled siRNA (5’- UUCUCCGAACGUGUCACG-3’) or RASA1 siRNA (5’-GCAGGCAGGGAAGUCUGGCAGUUAU-3’) using Lipofectamine 3000 (Invitrogen, L3000001). Both si-Scramble and si-RASA1 were purchased from Horizon Biosciences.</p></section><section id="sec023"><h3 class="pmc_sec_title">GTP-KRAS pull down assay</h3>
<p>The Active Ras Pull-Down and Detection Kit (cat # 16117, ThermoFisher) was used to assess GTP-Bound KRAS levels in HOS cells. The cells were seeded at a density of 6 × 10⁵ cells per 10-cm dish. The following day, HOS cells were transfected with scrambled siRNA or RASA1 and incubated for 48 hours. Following a wash with cold TBS, all steps were carried out in accordance with the manufacturer’s protocol (Active Ras Pull-Down and Detection Kit). HOS-143B cells were also included as a positive control for GTP-bound KRAS detection.</p></section><section id="sec024"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>All data are presented as mean ± standard deviation from three independent samples. Student’s t-test was conducted to assess the significance of two-group comparisons. For comparisons involving more than three groups, one-way ANOVA was performed, followed by Dunnett’s test for post-hoc analysis.</p></section></section><section id="sec025"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0329946.s001"><div class="caption p">
<span>S1 Fig. Structural characteristics of daraxonrasib and basal KRAS expression in HOS and HOS-143B cells.</span><p>(A) Structure of daraxonrasib, which contains a CYPA-binding domain. (B) Basal KRAS levels in HOS and HOS-143B cell lines. All experiments were conducted independently in triplicate, and the data are presented as the mean ± SD. Student’s T-tests were used to determine statistical significance. *<em>p</em> &lt; .05, **<em>p</em> &lt; .01, ***<em>p</em> &lt; .001.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333986/bin/pone.0329946.s001.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329946.s001.tif</a><sup> (126.1KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0329946.s002"><div class="caption p">
<span>S1 Data. Raw data.</span><p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333986/bin/pone.0329946.s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">pone.0329946.s002.pdf</a><sup> (917.3KB, pdf) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>All relevant data are within the manuscript and its <a href="#sec025" class="usa-link">Supporting Information</a> files.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This research was supported by NIGMS, NIH funding, 1 SC1GM131929-01A1, Dr. Shahana S. Mahajan MIB Agents Outsmarting Osteosarcoma Award, Dr. Shahana S. Mahajan PSC-CUNY Grant, 62504-00 50, Dr. Shahana S. Mahajan Dormitory Authority of the State of New York, GRTI 2022, Dr. Shahana S. Mahajan National Science Foundation, Award 2318923, Angelene Soto, Dr. Shahana S. Mahajan, Dr. Andrew L. Wolfe National Cancer Institute R00CA226363 Dr. Andrew L. Wolfe National Cancer Institute, U54CA22170, Dr. Andrew L. Wolfe Professional Staff Congress and City University of New York, ENHC55171, Dr. Andrew L. Wolfe Dormitory Authority of the State of New York, GRTI, Dr. Andrew L. Wolfe Hunter College of the City University of New York, Dr. Andrew L. Wolfe Oncogenuity Inc, Dr. Andrew L. Wolfe.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0329946.ref001">
<span class="label">1.</span><cite>Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bøhler PJ, et al. Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Acta Oncol. 2015;54(1):25–33. doi: 10.3109/0284186X.2014.923934

</cite> [<a href="https://doi.org/10.3109/0284186X.2014.923934" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4364276/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24957555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Oncol&amp;title=Time-trends%20on%20incidence%20and%20survival%20in%20a%20nationwide%20and%20unselected%20cohort%20of%20patients%20with%20skeletal%20osteosarcoma&amp;author=K%20Berner&amp;author=TB%20Johannesen&amp;author=A%20Berner&amp;author=HK%20Haugland&amp;author=B%20Bjerkehagen&amp;volume=54&amp;issue=1&amp;publication_year=2015&amp;pages=25-33&amp;pmid=24957555&amp;doi=10.3109/0284186X.2014.923934&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref002">
<span class="label">2.</span><cite>Yokoyama R, Schneider-Stock R, Radig K, Wex T, Roessner A. Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors. Pathol Res Pract. 1998;194(9):615–21. doi: 10.1016/s0344-0338(98)80096-4

</cite> [<a href="https://doi.org/10.1016/s0344-0338(98)80096-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9793960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathol%20Res%20Pract&amp;title=Clinicopathologic%20implications%20of%20MDM2,%20p53%20and%20K-ras%20gene%20alterations%20in%20osteosarcomas:%20MDM2%20amplification%20and%20p53%20mutations%20found%20in%20progressive%20tumors&amp;author=R%20Yokoyama&amp;author=R%20Schneider-Stock&amp;author=K%20Radig&amp;author=T%20Wex&amp;author=A%20Roessner&amp;volume=194&amp;issue=9&amp;publication_year=1998&amp;pages=615-21&amp;pmid=9793960&amp;doi=10.1016/s0344-0338(98)80096-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref003">
<span class="label">3.</span><cite>Zheng S, Zhou C, Qian G, Zhou Y, Shen Z, Yin Y. Mutational landscape of Chinese osteosarcoma patients. 2021.</cite>
</li>
<li id="pone.0329946.ref004">
<span class="label">4.</span><cite>Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–4. doi: 10.1158/2159-8290.CD-12-0095

</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-12-0095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3956037/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22588877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=The%20cBio%20cancer%20genomics%20portal:%20an%20open%20platform%20for%20exploring%20multidimensional%20cancer%20genomics%20data&amp;author=E%20Cerami&amp;author=J%20Gao&amp;author=U%20Dogrusoz&amp;author=BE%20Gross&amp;author=SO%20Sumer&amp;volume=2&amp;issue=5&amp;publication_year=2012&amp;pages=401-4&amp;pmid=22588877&amp;doi=10.1158/2159-8290.CD-12-0095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref005">
<span class="label">5.</span><cite>Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. doi: 10.1126/scisignal.2004088

</cite> [<a href="https://doi.org/10.1126/scisignal.2004088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4160307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23550210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Signal&amp;title=Integrative%20analysis%20of%20complex%20cancer%20genomics%20and%20clinical%20profiles%20using%20the%20cBioPortal&amp;author=J%20Gao&amp;author=BA%20Aksoy&amp;author=U%20Dogrusoz&amp;author=G%20Dresdner&amp;author=B%20Gross&amp;volume=6&amp;issue=269&amp;publication_year=2013&amp;pmid=23550210&amp;doi=10.1126/scisignal.2004088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref006">
<span class="label">6.</span><cite>de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, et al. Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Res. 2023;83(23):3861–7. doi: 10.1158/0008-5472.CAN-23-0816

</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-23-0816" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10690089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37668528/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Analysis%20and%20Visualization%20of%20Longitudinal%20Genomic%20and%20Clinical%20Data%20from%20the%20AACR%20Project%20GENIE%20Biopharma%20Collaborative%20in%20cBioPortal&amp;author=I%20de%20Bruijn&amp;author=R%20Kundra&amp;author=B%20Mastrogiacomo&amp;author=TN%20Tran&amp;author=L%20Sikina&amp;volume=83&amp;issue=23&amp;publication_year=2023&amp;pages=3861-7&amp;pmid=37668528&amp;doi=10.1158/0008-5472.CAN-23-0816&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref007">
<span class="label">7.</span><cite>Collisson EA, Bailey P, Chang DK, Biankin AV. Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2019;16(4):207–20. doi: 10.1038/s41575-019-0109-y

</cite> [<a href="https://doi.org/10.1038/s41575-019-0109-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30718832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Gastroenterol%20Hepatol&amp;title=Molecular%20subtypes%20of%20pancreatic%20cancer&amp;author=EA%20Collisson&amp;author=P%20Bailey&amp;author=DK%20Chang&amp;author=AV%20Biankin&amp;volume=16&amp;issue=4&amp;publication_year=2019&amp;pages=207-20&amp;pmid=30718832&amp;doi=10.1038/s41575-019-0109-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref008">
<span class="label">8.</span><cite>Cook JH, Melloni GEM, Gulhan DC, Park PJ, Haigis KM. The origins and genetic interactions of KRAS mutations are allele- and tissue-specific. Nat Commun. 2021;12(1):1808. doi: 10.1038/s41467-021-22125-z

</cite> [<a href="https://doi.org/10.1038/s41467-021-22125-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7985210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33753749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=The%20origins%20and%20genetic%20interactions%20of%20KRAS%20mutations%20are%20allele-%20and%20tissue-specific&amp;author=JH%20Cook&amp;author=GEM%20Melloni&amp;author=DC%20Gulhan&amp;author=PJ%20Park&amp;author=KM%20Haigis&amp;volume=12&amp;issue=1&amp;publication_year=2021&amp;pages=1808&amp;pmid=33753749&amp;doi=10.1038/s41467-021-22125-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref009">
<span class="label">9.</span><cite>Holderfield M, Lee BJ, Jiang J, Tomlinson A, Seamon KJ, Mira A. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy. Nature. 2024;:1–8.</cite> [<a href="https://doi.org/10.1038/s41586-024-07205-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11111408/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38589574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Concurrent%20inhibition%20of%20oncogenic%20and%20wild-type%20RAS-GTP%20for%20cancer%20therapy&amp;author=M%20Holderfield&amp;author=BJ%20Lee&amp;author=J%20Jiang&amp;author=A%20Tomlinson&amp;author=KJ%20Seamon&amp;publication_year=2024&amp;pages=1-8&amp;pmid=38589574&amp;doi=10.1038/s41586-024-07205-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref010">
<span class="label">10.</span><cite>Jiang J, Jiang L, Maldonato BJ, Wang Y, Holderfield M, Aronchik I, et al. Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers. Cancer Discov. 2024;14(6):994–1017. doi: 10.1158/2159-8290.CD-24-0027

</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-24-0027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11149917/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38593348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=Translational%20and%20Therapeutic%20Evaluation%20of%20RAS-GTP%20Inhibition%20by%20RMC-6236%20in%20RAS-Driven%20Cancers&amp;author=J%20Jiang&amp;author=L%20Jiang&amp;author=BJ%20Maldonato&amp;author=Y%20Wang&amp;author=M%20Holderfield&amp;volume=14&amp;issue=6&amp;publication_year=2024&amp;pages=994-1017&amp;pmid=38593348&amp;doi=10.1158/2159-8290.CD-24-0027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref011">
<span class="label">11.</span><cite>Ash LJ, Busia-Bourdain O, Okpattah D, Kamel A, Liberchuk A, Wolfe AL. KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance. Curr Oncol. 2024;31(4):2024–46. doi: 10.3390/curroncol31040150

</cite> [<a href="https://doi.org/10.3390/curroncol31040150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11049385/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38668053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Oncol&amp;title=KRAS:%20Biology,%20Inhibition,%20and%20Mechanisms%20of%20Inhibitor%20Resistance&amp;author=LJ%20Ash&amp;author=O%20Busia-Bourdain&amp;author=D%20Okpattah&amp;author=A%20Kamel&amp;author=A%20Liberchuk&amp;volume=31&amp;issue=4&amp;publication_year=2024&amp;pages=2024-46&amp;pmid=38668053&amp;doi=10.3390/curroncol31040150&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref012">
<span class="label">12.</span><cite>Schulze CJ, Seamon KJ, Zhao Y, Yang YC, Cregg J, Kim D. Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS. Science. 2023;381(6659):794–9.
</cite> [<a href="https://doi.org/10.1126/science.adg9652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10474815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37590355/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Chemical%20remodeling%20of%20a%20cellular%20chaperone%20to%20target%20the%20active%20state%20of%20mutant%20KRAS&amp;author=CJ%20Schulze&amp;author=KJ%20Seamon&amp;author=Y%20Zhao&amp;author=YC%20Yang&amp;author=J%20Cregg&amp;volume=381&amp;issue=6659&amp;publication_year=2023&amp;pages=794-9&amp;pmid=37590355&amp;doi=10.1126/science.adg9652&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref013">
<span class="label">13.</span><cite>Kim D, Herdeis L, Rudolph D, Zhao Y, Böttcher J, Vides A, et al. Pan-KRAS inhibitor disables oncogenic signalling and tumour growth. Nature. 2023;619(7968):160–6. doi: 10.1038/s41586-023-06123-3

</cite> [<a href="https://doi.org/10.1038/s41586-023-06123-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10322706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37258666/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Pan-KRAS%20inhibitor%20disables%20oncogenic%20signalling%20and%20tumour%20growth&amp;author=D%20Kim&amp;author=L%20Herdeis&amp;author=D%20Rudolph&amp;author=Y%20Zhao&amp;author=J%20B%C3%B6ttcher&amp;volume=619&amp;issue=7968&amp;publication_year=2023&amp;pages=160-6&amp;pmid=37258666&amp;doi=10.1038/s41586-023-06123-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref014">
<span class="label">14.</span><cite>Dillekås H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases?. Cancer medicine. 2019;8(12):5574–6.
</cite> [<a href="https://doi.org/10.1002/cam4.2474" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6745820/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31397113/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20medicine&amp;title=Are%2090%%20of%20deaths%20from%20cancer%20caused%20by%20metastases?&amp;author=H%20Dillek%C3%A5s&amp;author=MS%20Rogers&amp;author=O%20Straume&amp;volume=8&amp;issue=12&amp;publication_year=2019&amp;pages=5574-6&amp;pmid=31397113&amp;doi=10.1002/cam4.2474&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref015">
<span class="label">15.</span><cite>Reunanen N, Kähäri V. Matrix metalloproteinases in cancer cell invasion. Madame Curie Bioscience Database [Internet]: Landes Bioscience; 2013.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinases%20in%20cancer%20cell%20invasion.%20Madame%20Curie%20Bioscience%20Database%20%5BInternet%5D:%20Landes%20Bioscience&amp;author=N%20Reunanen&amp;author=V%20K%C3%A4h%C3%A4ri&amp;publication_year=2013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref016">
<span class="label">16.</span><cite>Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123(Pt 24):4195–200. doi: 10.1242/jcs.023820

</cite> [<a href="https://doi.org/10.1242/jcs.023820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2995612/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21123617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cell%20Sci&amp;title=The%20extracellular%20matrix%20at%20a%20glance&amp;author=C%20Frantz&amp;author=KM%20Stewart&amp;author=VM%20Weaver&amp;volume=123&amp;publication_year=2010&amp;pages=4195-200&amp;pmid=21123617&amp;doi=10.1242/jcs.023820&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref017">
<span class="label">17.</span><cite>Nomura TK, Endo S, Kuwano T, Fukasawa K, Takashima S, Todo T, et al. ARL-17477 is a dual inhibitor of NOS1 and the autophagic-lysosomal system that prevents tumor growth in vitro and in vivo. Sci Rep. 2023;13(1):10757. doi: 10.1038/s41598-023-37797-4

</cite> [<a href="https://doi.org/10.1038/s41598-023-37797-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10319805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37402770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=ARL-17477%20is%20a%20dual%20inhibitor%20of%20NOS1%20and%20the%20autophagic-lysosomal%20system%20that%20prevents%20tumor%20growth%20in%20vitro%20and%20in%20vivo&amp;author=TK%20Nomura&amp;author=S%20Endo&amp;author=T%20Kuwano&amp;author=K%20Fukasawa&amp;author=S%20Takashima&amp;volume=13&amp;issue=1&amp;publication_year=2023&amp;pages=10757&amp;pmid=37402770&amp;doi=10.1038/s41598-023-37797-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref018">
<span class="label">18.</span><cite>Botter SM, Arlt MJ, Born W, Fuchs B. Mammalian models of bone sarcomas. Bone Cancer. Elsevier. 2015. p. 349–63.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Bone%20Cancer&amp;author=SM%20Botter&amp;author=MJ%20Arlt&amp;author=W%20Born&amp;author=B%20Fuchs&amp;publication_year=2015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref019">
<span class="label">19.</span><cite>Doppelt-Flikshtain O, Younis A, Tamari T, Ginesin O, Shentzer-Kutiel T, Nikomarov D, et al. Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling. Cancers (Basel). 2023;15(6):1818. doi: 10.3390/cancers15061818

</cite> [<a href="https://doi.org/10.3390/cancers15061818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10046883/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36980704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Endothelial%20Progenitor%20Cells%20Promote%20Osteosarcoma%20Progression%20and%20Invasiveness%20via%20AKT/PI3K%20Signaling&amp;author=O%20Doppelt-Flikshtain&amp;author=A%20Younis&amp;author=T%20Tamari&amp;author=O%20Ginesin&amp;author=T%20Shentzer-Kutiel&amp;volume=15&amp;issue=6&amp;publication_year=2023&amp;pages=1818&amp;pmid=36980704&amp;doi=10.3390/cancers15061818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref020">
<span class="label">20.</span><cite>Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000;18(5):1135–49. doi: 10.1200/JCO.2000.18.5.1135

</cite> [<a href="https://doi.org/10.1200/JCO.2000.18.5.1135" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10694567/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Matrix%20metalloproteinases:%20biologic%20activity%20and%20clinical%20implications&amp;author=AR%20Nelson&amp;author=B%20Fingleton&amp;author=ML%20Rothenberg&amp;author=LM%20Matrisian&amp;volume=18&amp;issue=5&amp;publication_year=2000&amp;pages=1135-49&amp;pmid=10694567&amp;doi=10.1200/JCO.2000.18.5.1135&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref021">
<span class="label">21.</span><cite>Mazor R, Alsaigh T, Shaked H, Altshuler AE, Pocock ES, Kistler EB, et al. Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells. J Biol Chem. 2013;288(1):598–607. doi: 10.1074/jbc.M112.417451

</cite> [<a href="https://doi.org/10.1074/jbc.M112.417451" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3537058/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23155052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=Matrix%20metalloproteinase-1-mediated%20up-regulation%20of%20vascular%20endothelial%20growth%20factor-2%20in%20endothelial%20cells&amp;author=R%20Mazor&amp;author=T%20Alsaigh&amp;author=H%20Shaked&amp;author=AE%20Altshuler&amp;author=ES%20Pocock&amp;volume=288&amp;issue=1&amp;publication_year=2013&amp;pages=598-607&amp;pmid=23155052&amp;doi=10.1074/jbc.M112.417451&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref022">
<span class="label">22.</span><cite>Doppelt-Flikshtain O, Asbi T, Younis A, Ginesin O, Cohen Z, Tamari T. Inhibition of osteosarcoma metastasis in vivo by targeted downregulation of MMP1 and MMP9. Matrix Biology. 2024.</cite> [<a href="https://doi.org/10.1016/j.matbio.2024.09.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39278602/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Matrix%20Biology&amp;title=Inhibition%20of%20osteosarcoma%20metastasis%20in%20vivo%20by%20targeted%20downregulation%20of%20MMP1%20and%20MMP9&amp;author=O%20Doppelt-Flikshtain&amp;author=T%20Asbi&amp;author=A%20Younis&amp;author=O%20Ginesin&amp;author=Z%20Cohen&amp;publication_year=2024&amp;pmid=39278602&amp;doi=10.1016/j.matbio.2024.09.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref023">
<span class="label">23.</span><cite>Cregg J, Edwards AV, Chang S, Lee BJ, Knox JE, Tomlinson ACA, et al. Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers. J Med Chem. 2025;68(6):6064–83. doi: 10.1021/acs.jmedchem.4c02314

</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.4c02314" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40056080/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Chem&amp;title=Discovery%20of%20Daraxonrasib%20(RMC-6236),%20a%20Potent%20and%20Orally%20Bioavailable%20RAS(ON)%20Multi-selective,%20Noncovalent%20Tri-complex%20Inhibitor%20for%20the%20Treatment%20of%20Patients%20with%20Multiple%20RAS-Addicted%20Cancers&amp;author=J%20Cregg&amp;author=AV%20Edwards&amp;author=S%20Chang&amp;author=BJ%20Lee&amp;author=JE%20Knox&amp;volume=68&amp;issue=6&amp;publication_year=2025&amp;pages=6064-83&amp;pmid=40056080&amp;doi=10.1021/acs.jmedchem.4c02314&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref024">
<span class="label">24.</span><cite>Chen C, Jiang Y-P, You I, Gray NS, Lin RZ. Down-Regulation of AKT Proteins Slows the Growth of Mutant-KRAS Pancreatic Tumors. Cells. 2024;13(12):1061. doi: 10.3390/cells13121061

</cite> [<a href="https://doi.org/10.3390/cells13121061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11202146/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38920688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Down-Regulation%20of%20AKT%20Proteins%20Slows%20the%20Growth%20of%20Mutant-KRAS%20Pancreatic%20Tumors&amp;author=C%20Chen&amp;author=Y-P%20Jiang&amp;author=I%20You&amp;author=NS%20Gray&amp;author=RZ%20Lin&amp;volume=13&amp;issue=12&amp;publication_year=2024&amp;pages=1061&amp;pmid=38920688&amp;doi=10.3390/cells13121061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref025">
<span class="label">25.</span><cite>Phuchareon J, McCormick F, Eisele DW, Tetsu O. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function. Proc Natl Acad Sci U S A. 2015;112(29):E3855-63. doi: 10.1073/pnas.1510733112

</cite> [<a href="https://doi.org/10.1073/pnas.1510733112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4517222/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26150526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=EGFR%20inhibition%20evokes%20innate%20drug%20resistance%20in%20lung%20cancer%20cells%20by%20preventing%20Akt%20activity%20and%20thus%20inactivating%20Ets-1%20function&amp;author=J%20Phuchareon&amp;author=F%20McCormick&amp;author=DW%20Eisele&amp;author=O%20Tetsu&amp;volume=112&amp;issue=29&amp;publication_year=2015&amp;pmid=26150526&amp;doi=10.1073/pnas.1510733112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref026">
<span class="label">26.</span><cite>Van Beek JP, Kennedy L, Rockel JS, Bernier SM, Leask A. The induction of CCN2 by TGFβ1 involves Ets-1. Arthritis research &amp; therapy. 2006;8:1–9.</cite> [<a href="https://doi.org/10.1186/ar1890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1526589/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16469114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis%20research%20&amp;%20therapy&amp;title=The%20induction%20of%20CCN2%20by%20TGF%CE%B21%20involves%20Ets-1&amp;author=JP%20Van%20Beek&amp;author=L%20Kennedy&amp;author=JS%20Rockel&amp;author=SM%20Bernier&amp;author=A%20Leask&amp;volume=8&amp;publication_year=2006&amp;pages=1-9&amp;pmid=16469114&amp;doi=10.1186/ar1890&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref027">
<span class="label">27.</span><cite>Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. Journal of Biological Chemistry. 2006;281(35):25259–69.
</cite> [<a href="https://doi.org/10.1074/jbc.M600466200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16829517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biological%20Chemistry&amp;title=Fli1%20and%20Ets1%20have%20distinct%20roles%20in%20connective%20tissue%20growth%20factor/CCN2%20gene%20regulation%20and%20induction%20of%20the%20profibrotic%20gene%20program&amp;author=SS%20Nakerakanti&amp;author=B%20Kapanadze&amp;author=M%20Yamasaki&amp;author=M%20Markiewicz&amp;author=M%20Trojanowska&amp;volume=281&amp;issue=35&amp;publication_year=2006&amp;pages=25259-69&amp;pmid=16829517&amp;doi=10.1074/jbc.M600466200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref028">
<span class="label">28.</span><cite>Tang D, Kroemer G, Kang R. Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges. Molecular Cancer. 2021;20(1):128.
</cite> [<a href="https://doi.org/10.1186/s12943-021-01422-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8489073/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34607583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Cancer&amp;title=Oncogenic%20KRAS%20blockade%20therapy:%20renewed%20enthusiasm%20and%20persistent%20challenges&amp;author=D%20Tang&amp;author=G%20Kroemer&amp;author=R%20Kang&amp;volume=20&amp;issue=1&amp;publication_year=2021&amp;pages=128&amp;pmid=34607583&amp;doi=10.1186/s12943-021-01422-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref029">
<span class="label">29.</span><cite>Simanshu DK, Morrison DK. A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation. Cancer Discov. 2022;12(4):899–912. doi: 10.1158/2159-8290.CD-21-1494

</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-21-1494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8983508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35046094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=A%20Structure%20is%20Worth%20a%20Thousand%20Words:%20New%20Insights%20for%20RAS%20and%20RAF%20Regulation&amp;author=DK%20Simanshu&amp;author=DK%20Morrison&amp;volume=12&amp;issue=4&amp;publication_year=2022&amp;pages=899-912&amp;pmid=35046094&amp;doi=10.1158/2159-8290.CD-21-1494&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref030">
<span class="label">30.</span><cite>Yaeger R, Mezzadra R, Sinopoli J, Bian Y, Marasco M, Kaplun E, et al. Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer. Cancer Discov. 2023;13(1):41–55. doi: 10.1158/2159-8290.CD-22-0405

</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-22-0405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9827113/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36355783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=Molecular%20Characterization%20of%20Acquired%20Resistance%20to%20KRASG12C-EGFR%20Inhibition%20in%20Colorectal%20Cancer&amp;author=R%20Yaeger&amp;author=R%20Mezzadra&amp;author=J%20Sinopoli&amp;author=Y%20Bian&amp;author=M%20Marasco&amp;volume=13&amp;issue=1&amp;publication_year=2023&amp;pages=41-55&amp;pmid=36355783&amp;doi=10.1158/2159-8290.CD-22-0405&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref031">
<span class="label">31.</span><cite>Ji J, Wang C, Fakih M. Targeting KRAS G12C-mutated advanced colorectal cancer: research and clinical developments. OncoTargets and Therapy. 2022;:747–56.
</cite> [<a href="https://doi.org/10.2147/OTT.S340392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9273901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35837349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=OncoTargets%20and%20Therapy&amp;title=Targeting%20KRAS%20G12C-mutated%20advanced%20colorectal%20cancer:%20research%20and%20clinical%20developments&amp;author=J%20Ji&amp;author=C%20Wang&amp;author=M%20Fakih&amp;publication_year=2022&amp;pages=747-56&amp;pmid=35837349&amp;doi=10.2147/OTT.S340392&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref032">
<span class="label">32.</span><cite>Hong DS, Fakih MG, Strickler JH, Desai J, Durm GA, Shapiro GI, et al. KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors. N Engl J Med. 2020;383(13):1207–17. doi: 10.1056/NEJMoa1917239

</cite> [<a href="https://doi.org/10.1056/NEJMoa1917239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7571518/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32955176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=KRASG12C%20Inhibition%20with%20Sotorasib%20in%20Advanced%20Solid%20Tumors&amp;author=DS%20Hong&amp;author=MG%20Fakih&amp;author=JH%20Strickler&amp;author=J%20Desai&amp;author=GA%20Durm&amp;volume=383&amp;issue=13&amp;publication_year=2020&amp;pages=1207-17&amp;pmid=32955176&amp;doi=10.1056/NEJMoa1917239&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref033">
<span class="label">33.</span><cite>Jänne PA, Riely GJ, Gadgeel SM, Heist RS, Ou S-HI, Pacheco JM, et al. Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation. N Engl J Med. 2022;387(2):120–31. doi: 10.1056/NEJMoa2204619

</cite> [<a href="https://doi.org/10.1056/NEJMoa2204619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35658005/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Adagrasib%20in%20Non-Small-Cell%20Lung%20Cancer%20Harboring%20a%20KRASG12C%20Mutation&amp;author=PA%20J%C3%A4nne&amp;author=GJ%20Riely&amp;author=SM%20Gadgeel&amp;author=RS%20Heist&amp;author=S-HI%20Ou&amp;volume=387&amp;issue=2&amp;publication_year=2022&amp;pages=120-31&amp;pmid=35658005&amp;doi=10.1056/NEJMoa2204619&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref034">
<span class="label">34.</span><cite>Noll B, Mougeot FB, Brennan MT, Mougeot J-LC. Regulation of MMP9 transcription by ETS1 in immortalized salivary gland epithelial cells of patients with salivary hypofunction and primary Sjögren’s syndrome. Sci Rep. 2022;12(1):14552. doi: 10.1038/s41598-022-18576-z

</cite> [<a href="https://doi.org/10.1038/s41598-022-18576-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9411565/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36008454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Regulation%20of%20MMP9%20transcription%20by%20ETS1%20in%20immortalized%20salivary%20gland%20epithelial%20cells%20of%20patients%20with%20salivary%20hypofunction%20and%20primary%20Sj%C3%B6gren%E2%80%99s%20syndrome&amp;author=B%20Noll&amp;author=FB%20Mougeot&amp;author=MT%20Brennan&amp;author=J-LC%20Mougeot&amp;volume=12&amp;issue=1&amp;publication_year=2022&amp;pages=14552&amp;pmid=36008454&amp;doi=10.1038/s41598-022-18576-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref035">
<span class="label">35.</span><cite>Nazir SU, Kumar R, Singh A, Khan A, Tanwar P, Tripathi R. Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor. Gene. 2019;711:143952.
</cite> [<a href="https://doi.org/10.1016/j.gene.2019.143952" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31265880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gene&amp;title=Breast%20cancer%20invasion%20and%20progression%20by%20MMP-9%20through%20Ets-1%20transcription%20factor&amp;author=SU%20Nazir&amp;author=R%20Kumar&amp;author=A%20Singh&amp;author=A%20Khan&amp;author=P%20Tanwar&amp;volume=711&amp;publication_year=2019&amp;pages=143952&amp;pmid=31265880&amp;doi=10.1016/j.gene.2019.143952&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref036">
<span class="label">36.</span><cite>Cao P, Feng F, Dong G, Yu C, Feng S, Song E, et al. Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner. BMC Cancer. 2015;15:491. doi: 10.1186/s12885-015-1495-3

</cite> [<a href="https://doi.org/10.1186/s12885-015-1495-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4486695/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26122040/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Estrogen%20receptor%20%CE%B1%20enhances%20the%20transcriptional%20activity%20of%20ETS-1%20and%20promotes%20the%20proliferation,%20migration%20and%20invasion%20of%20neuroblastoma%20cell%20in%20a%20ligand%20dependent%20manner&amp;author=P%20Cao&amp;author=F%20Feng&amp;author=G%20Dong&amp;author=C%20Yu&amp;author=S%20Feng&amp;volume=15&amp;publication_year=2015&amp;pages=491&amp;pmid=26122040&amp;doi=10.1186/s12885-015-1495-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref037">
<span class="label">37.</span><cite>Lee YJ, Jung O, Lee J, Son J, Cho JY, Ryou C, et al. Maclurin exerts anti-cancer effects on PC3 human prostate cancer cells via activation of p38 and inhibitions of JNK, FAK, AKT, and c-Myc signaling pathways. Nutr Res. 2018;58:62–71. doi: 10.1016/j.nutres.2018.07.003

</cite> [<a href="https://doi.org/10.1016/j.nutres.2018.07.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30340816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nutr%20Res&amp;title=Maclurin%20exerts%20anti-cancer%20effects%20on%20PC3%20human%20prostate%20cancer%20cells%20via%20activation%20of%20p38%20and%20inhibitions%20of%20JNK,%20FAK,%20AKT,%20and%20c-Myc%20signaling%20pathways&amp;author=YJ%20Lee&amp;author=O%20Jung&amp;author=J%20Lee&amp;author=J%20Son&amp;author=JY%20Cho&amp;volume=58&amp;publication_year=2018&amp;pages=62-71&amp;pmid=30340816&amp;doi=10.1016/j.nutres.2018.07.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref038">
<span class="label">38.</span><cite>Jung O, Lee J, Lee YJ, Yun J-M, Son Y-J, Cho JY, et al. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways. Bioorg Med Chem Lett. 2016;26(16):3963–7. doi: 10.1016/j.bmcl.2016.07.004

</cite> [<a href="https://doi.org/10.1016/j.bmcl.2016.07.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27422337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg%20Med%20Chem%20Lett&amp;title=Timosaponin%20AIII%20inhibits%20migration%20and%20invasion%20of%20A549%20human%20non-small-cell%20lung%20cancer%20cells%20via%20attenuations%20of%20MMP-2%20and%20MMP-9%20by%20inhibitions%20of%20ERK1/2,%20Src/FAK%20and%20%CE%B2-catenin%20signaling%20pathways&amp;author=O%20Jung&amp;author=J%20Lee&amp;author=YJ%20Lee&amp;author=J-M%20Yun&amp;author=Y-J%20Son&amp;volume=26&amp;issue=16&amp;publication_year=2016&amp;pages=3963-7&amp;pmid=27422337&amp;doi=10.1016/j.bmcl.2016.07.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref039">
<span class="label">39.</span><cite>Chakrabarti S, Patel KD. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J Leukoc Biol. 2005;78(1):279–88. doi: 10.1189/jlb.1004612

</cite> [<a href="https://doi.org/10.1189/jlb.1004612" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15831558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Leukoc%20Biol&amp;title=Regulation%20of%20matrix%20metalloproteinase-9%20release%20from%20IL-8-stimulated%20human%20neutrophils&amp;author=S%20Chakrabarti&amp;author=KD%20Patel&amp;volume=78&amp;issue=1&amp;publication_year=2005&amp;pages=279-88&amp;pmid=15831558&amp;doi=10.1189/jlb.1004612&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref040">
<span class="label">40.</span><cite>Sun B, Rong R, Jiang H, Zhang H, Wang Y, Bai X. Prostaglandin E 2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells. Molecular and Cellular Biochemistry. 2013;378:195–203.
</cite> [<a href="https://doi.org/10.1007/s11010-013-1610-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23494562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Biochemistry&amp;title=Prostaglandin%20E%202%20receptor%20EP1%20phosphorylate%20CREB%20and%20mediates%20MMP2%20expression%20in%20human%20cholangiocarcinoma%20cells&amp;author=B%20Sun&amp;author=R%20Rong&amp;author=H%20Jiang&amp;author=H%20Zhang&amp;author=Y%20Wang&amp;volume=378&amp;publication_year=2013&amp;pages=195-203&amp;pmid=23494562&amp;doi=10.1007/s11010-013-1610-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref041">
<span class="label">41.</span><cite>Steven A, Seliger B. Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target. Oncotarget. 2016;7(23):35454–65. doi: 10.18632/oncotarget.7721

</cite> [<a href="https://doi.org/10.18632/oncotarget.7721" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5085243/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26934558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Control%20of%20CREB%20expression%20in%20tumors:%20from%20molecular%20mechanisms%20and%20signal%20transduction%20pathways%20to%20therapeutic%20target&amp;author=A%20Steven&amp;author=B%20Seliger&amp;volume=7&amp;issue=23&amp;publication_year=2016&amp;pages=35454-65&amp;pmid=26934558&amp;doi=10.18632/oncotarget.7721&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329946.ref042">
<span class="label">42.</span><cite>Kornhauser JM, Cowan CW, Shaywitz AJ, Dolmetsch RE, Griffith EC, Hu LS, et al. CREB transcriptional activity in neurons is regulated by multiple, calcium-specific phosphorylation events. Neuron. 2002;34(2):221–33. doi: 10.1016/s0896-6273(02)00655-4

</cite> [<a href="https://doi.org/10.1016/s0896-6273(02)00655-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11970864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=CREB%20transcriptional%20activity%20in%20neurons%20is%20regulated%20by%20multiple,%20calcium-specific%20phosphorylation%20events&amp;author=JM%20Kornhauser&amp;author=CW%20Cowan&amp;author=AJ%20Shaywitz&amp;author=RE%20Dolmetsch&amp;author=EC%20Griffith&amp;volume=34&amp;issue=2&amp;publication_year=2002&amp;pages=221-33&amp;pmid=11970864&amp;doi=10.1016/s0896-6273(02)00655-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 Fig. Structural characteristics of daraxonrasib and basal KRAS expression in HOS and HOS-143B cells.</span><p>(A) Structure of daraxonrasib, which contains a CYPA-binding domain. (B) Basal KRAS levels in HOS and HOS-143B cell lines. All experiments were conducted independently in triplicate, and the data are presented as the mean ± SD. Student’s T-tests were used to determine statistical significance. *<em>p</em> &lt; .05, **<em>p</em> &lt; .01, ***<em>p</em> &lt; .001.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333986/bin/pone.0329946.s001.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329946.s001.tif</a><sup> (126.1KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S1 Data. Raw data.</span><p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333986/bin/pone.0329946.s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">pone.0329946.s002.pdf</a><sup> (917.3KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All relevant data are within the manuscript and its <a href="#sec025" class="usa-link">Supporting Information</a> files.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0329946"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0329946.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12333986/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12333986/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12333986%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333986/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12333986/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12333986/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40779492/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12333986/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40779492/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12333986/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12333986/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="umf0Zh57ek4BbH4XsDB9GfTxESVoMNa3fkKD11hXO9cgYK9sYwdW2lhyDVRgaFcE">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
